Match Document Document Title
US20150099740 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS  
A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention...
US20140255491 Method and System For the Treatment of Chronic Obstructive Pulmonary Disease With Nebulized Anticholinergic Administrations  
Inhalation solutions for administration of muscarinic antagonists for the treatment of breathing disorders, such as COPD, are provided.
US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same  
Compositions and methods for the detection and treatment of schizophrenia are provided.
US20140271862 Rapid Disperse Dosage Form Containing Levetiracetam  
A high dose rapidly dispersing three-dimensionally printed dosage form comprising a high dose of levetiracetam in a porous matrix that disperses in water within a period of less than about 10...
US20070243260 Treatment of Childhood Asthma  
Glycopyrrolate or an analogue thereof is useful for the treatment of childhood asthma.
US20090060922 Acetamide Stereoisomer  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible...
US20140038943 SEROTONIN RECEPTOR MODULATOR  
Certain biphenyic compounds are serotonin modulators useful in the treatment of serotonin-mediated diseases.
US20140179752 METHODS OF TREATING SOFT TISSUE DEFECTS  
The specification discloses compositions and methods for treating a soft tissue defect of an individual.
US20120214859 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION  
This invention relates to methods and compositions for treating central nervous system (CNS) disorders with cognitive impairment. In particular, it relates to the use of inhibitors of synaptic...
US20150099788 CONTROLLED RELEASE ORAL FORMULATIONS OF ION CHANNEL MODULATING COMPOUNDS AND RELATED METHODS FOR PREVENTING ARRHYTHMIA  
The present invention provides methods of treating and preventing arrhythmia and other diseases or disorders, using ion channel modulating compounds, including vernakalant hydrochloride. The...
US20110136779 METHODS FOR STROKE REDUCTION IN ATRIAL FIBRILLATION PATIENTS  
The subject invention provides methods for reducing stroke rate, methods for preventing atrial remodeling, and methods for reversing atrial remodeling by administering a multiple ion channel...
US20120071426 METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER  
The present invention provides methods and compositions for treating lung cancer by cyclohexenone compounds.
US20110201665 Compositions, Methods, and Kits for Treating Influenza Viral Infections  
The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
US20110028510 Compositions, Methods, and Kits for Treating Influenza Viral Infections  
The present invention provides compositions, methods, and kits for treating or preventing a viral infection (e.g., an infection caused by an influenza virus).
US20140341979 NANODRUG TARGETING PROTEIN GERANYLGERANYLATION  
The present invention relates, for example, to a liposome, which can be a basic liposome, a transferrin-conjugated liposome, or a pH-sensitive liposome, which encapsulates a compound that...
US20140161867 METHOD OF TOPICALLY APPLYING GLYCOPYRROLATE SOLUTION USING ABSORBENT PAD TO REDUCE SWEATING  
This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this...
US20120237573 METHOD OF TOPICALLY APPLYING GLYCOPYRROLATE SOLUTION USING ABSORBENT PAD TO REDUCE SWEATING  
This invention relates to a convenient and safe product and method of applying glycopyrrolate topically in order to reduce excessive sweating in localized areas for those who suffer from this...
US20130005718 COMPOSITIONS AND METHODS OF TREATING CHRONIC PAIN BY ADMINISTERING PROPOFOL DERIVATIVES  
Compositions and methods for managing or treating chronic pain are provided. More particularly, methods are provided for managing or treating chronic pain by administering to a patient in need...
US20110076244 SURFACE COATINGS FOR SKIN  
The present invention relates to skin coating compositions and methods and, in particular, to coatings containing an active agent. In some embodiments, the coating may be applied to a skin surface...
US20150051233 METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS  
Embodiments of the invention include methods of treating, preventing, and/or reducing the risk of fibrosis in an individual in need thereof. In some embodiments, particular small molecules are...
US20130331394 TREATING SCHIZOPHRENIA  
Methods of identifying new treatments for schizophrenia, and the use of the same.
US20150150802 DRY POWDER INHALER COMPOSITIONS COMPRISING LONG ACTING MUSCARINIC ANTAGONISTS  
This invention relates to novel pharmaceutical compositions for inhalation comprising separately or together the long acting muscorinic antagonists (LAMAs) in the form of a dry powder in admixture...
US20060178426 Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome  
Compound of the formula (I), in which A, R1, R2, R3, X, Y, m and n have the meaning indicated, are suitable as for the treatment of irritable bowel syndrome.
US20110305640 METHOD TO TREAT PSORIASIS AND OTHER HYPERPROLIFERATIVE SKIN DISORDERS  
Soluble adenylyl cyclase (sAC) is implicated in proliferation of keratinocytes. Inhibitors of sAC are useful for the treatment and/or prevention of psoriasis and other hyperproliferative skin...
US20120129833 CYCLIC KETOENOLS FOR THERAPY  
The invention relates to 5′-biphenyl-substituted cyclic ketoenols for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and...
US20140243396 METHOD OF TREATING MUCOEPIDERMOID CARCINOMA  
Imidazoquinolines, as set forth in formula (I), are useful for inhibiting growth or proliferation of mucoepidermoid carcinoma cells. The therapeutic and prophylactic treatments provided by this...
US20110207714 SEROTONIN RECEPTOR MODULATORS  
The biphenyic compounds of formula (I) are serotonin modulators useful in the treatment of serotonin-mediated diseases.
US20150037425 POWDER COMPOSITIONS FOR INHALATION  
The present invention relates to pharmaceutical powders for inhalation produced by a method consisting of a first step of mixing particles of a force-controlling agent selected from a salt of a...
US20120328704 POWDER COMPOSITIONS FOR INHALATION  
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also...
US20130202705 ALCOHOL-RESISTANT FORMULATIONS  
This disclosure relates to an extended release oral dosage form comprising a matrix containing a viscosity modifier (but no lipid) and coated granules containing a high water-soluble, high dose...
US20120269762 CAUSAL THERAPY OF DISEASES OR CONDITIONS ASSOCIATED WITH CNS OR PNS DEMYELINATION  
The invention broadly relates to the use of the Active in the causal treatment of a disease caused by axonal demyelination, in which the Active maintains the integrity of myelination (for example...
US20110178152 COMPOSITION COMPRISING S-ALLYLMERCAPTO-N-ACETYLCYSTEINE (ASSNAC) FOR UP-REGULATION OF CELLULAR GLUTATHIONE LEVEL  
The present invention relates to S-allylmercapto-N-acetylcysteine (ASSNAC) and its pharmaceutically acceptable salts and solvates, which are useful for up-regulation of cellular glutathione levels...
US20140011772 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION  
The present invention relates to compositions and methods for the treating and empirically investigating conditions associated with neuronal dysfunction (e.g., chronic pain, epileptic neuronal...
US20110236492 DRY POWDER INHALER FORMULATIONS COMPRISING SURFACE-MODIFIED PARTICLES WITH ANTI-ADHERENT ADDITIVES  
The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler...
US20110305645 CRYSTAL FORM OF GLYCOPYRRONIUM CHLORIDE  
A new crystal form of threo glycopyrronium chloride is useful in pharmaceutical applications.
US20140243341 BROAD-SPECTRUM ANTIVIRALS AGAINST 3C OR 3C-LIKE PROTEASES OF PICORNAVIRUS-LIKE SUPERCLUSTER: PICORNAVIRUSES, CALICIVIRUSES AND CORONAVIRUSES  
Antiviral protease inhibitors, including peptidyl aldehydes, peptidyl α-ketoamides, peptidyl bisulfite salts, and peptidyl heterocycles, are disclosed, along with related antiviral compounds, and...
US20130202667 HYDROGEL PARTICLE COATED WITH LIPID AND METHOD FOR MANUFACTURING SAME  
The present invention relates to hydrogel particles coated with lipid, which are made from dispersing hydrogel particles in an organic solvent in which lipids are dissolved, and to a method for...
US20150051161 Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease  
The present invention provides compositions and methods for detecting carboxymethyl-lysine (CML) and circulating receptor for advanced glycation end (RAGE) products, and methods for correlating...
US20130317013 EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF  
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are...
US20110059909 METHODS FOR TREATING INFLAMMATORY DISORDERS  
The present invention relates generally to the fields of molecular biology. More particularly, it concerns materials and methods for the treatment of nitric oxide and cytokind mediated disorders....
US20150094352 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION  
This invention relates to treating age-related cognitive impairment. This invention in particular relates to the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam,...
US20120046336 METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION  
This invention relates to treating age-related cognitive impairment. This invention in particular relates to the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam,...
US20080114014 NEW USES FOR QUATERNARY AMMONIUM ANTICHOLINERGIC MUSCARINIC RECEPTOR ANTAGONISTS IN PATIENTS BEING TREATED FOR COGNITIVE IMPAIRMENT OR ACUTE DELIRIUM  
A method for treating the adverse effects of acetyl-cholinesterase inhibitors used in the treatment of cognitive disorders such as acute delirium and cognitive impairment in elderly human...
US20080090859 Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy  
The instant invention relates to the use of compounds that are effective as selective opiate receptor modulators for the manufacture of a pharmaceutical for the diagnosis, prophylaxis and/or the...
US20120046332 COMPOSITIONS AND METHODS FOR TREATING CORNEAL HAZE  
Disclosed herein are compositions and methods for treating corneal haze. Compositions and methods of use comprise therapeutically effective amounts of compounds that agonize the EP2 and/or EP4...
US20130053385 METHOD OF COMBATING AND CONTROLLING PESTS  
The use of a compound of formula I wherein the substituents are as defined in claim 1, or compositions containing them in controlling insects, acarines, nematodes or molluscs.
US20110319790 PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES  
Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition...
US20150196532 Glycopyrrolate Salts  
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof,...
US20140371290 Glycopyrrolate Salts  
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof,...
US20140135300 Acetamide Stereoisomer  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible...